Leptin levels and risk of type 2 diabetes: Gender-specific meta-analysis

Obesity Reviews

Volumn 15, Issue 2, 2014, Pages 134-142

  Chen, G C ^a   Qin, L Q ^b   Ye, J K ^c  

^a NINGBO MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SOOCHOW UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Adipocytokines; Leptin; Meta analysis; Type 2 diabetes

Indexed keywords

LEPTIN;

DOSE RESPONSE; GENDER; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; REVIEW; RISK FACTOR;

ADIPOCYTOKINES; LEPTIN; META-ANALYSIS; TYPE 2 DIABETES;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LEPTIN; MALE; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84892833413     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12088     Document Type: Review

References (39)

1. Fehmann HC, Berghofer P, Brandhorst D etal. Leptin inhibition of insulin secretion from isolated human islets. Acta Diabetol 1997; 34: 249-252.
2. Fehmann HC, Peiser C, Bode HP etal. Leptin: a potent inhibitor of insulin secretion. Peptides 1997; 18: 1267-1273.
3. Seufert J, Kieffer TJ, Leech CA etal. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 670-676.
4. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A 1999; 96: 674-679.
5. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 2000; 278: E1-E14.
6. Bandaru P, Shankar A. Association between plasma leptin levels and diabetes mellitus. Metab Syndr Relat Disord 2011; 9: 19-23.
7. Lilja M, Rolandsson O, Norberg M, Soderberg S. The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord 2012; 10: 143-151.
8. McNeely MJ, Boyko EJ, Weigle DS etal. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999; 22: 65-70.
9. Sans S, Padro T, Tuomilehto J, Badimon L. Incidence of diabetes and serum adipokines in Catalonian men: the ADIPOCAT study. Ann Med 2013; 45: 97-102.
10. Schmidt MI, Duncan BB, Vigo A etal. Leptin and incident type 2 diabetes: risk or protection? Diabetologia 2006; 49: 2086-2096.
11. Snijder MB, Dekker JM, Bouter LM, Heine RJ, Stehouwer CD, Seidell JC. Comment on: Schmidt MI, Duncan BB, Vigo A etal. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086-2096. Diabetologia 2007; 50: 234-236; author reply 237-238; discussion 239-240.
12. Soderberg S, Zimmet P, Tuomilehto J etal. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 2007; 31: 1126-1133.
13. Sun Q, van Dam RM, Meigs JB, Franco OH, Mantzoros CS, Hu FB. Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes 2010; 59: 611-618.
14. Thorand B, Zierer A, Baumert J, Meisinger C, Herder C, Koenig W. Associations between leptin and the leptin/adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA/KORA Augsburg study 1984-2002. Diabet Med 2010; 27: 1004-1011.
15. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007; 30: 1200-1205.
16. Welsh P, Murray HM, Buckley BM etal. Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 2009; 32: 308-310.
17. Kanaya AM, Wassel Fyr C, Vittinghoff E etal. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Arch Intern Med 2006; 166: 350-356.
18. Ley SH, Harris SB, Connelly PW etal. Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project. Diabetes Care 2008; 31: 1410-1415.
19. Marques-Vidal P, Schmid R, Bochud M etal. Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study. PLoS ONE 2012; 7: e51768.
20. Myers MG Jr. Outstanding Scientific Achievement Award Lecture 2010: deconstructing leptin: from signals to circuits. Diabetes 2010; 59: 2708-2714.
21. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
22. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
23. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-respose data. Stata J 2006; 6: 40-57.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
25. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
28. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-1433.
29. Amitani M, Asakawa A, Amitani H, Inui A. The role of leptin in the control of insulin-glucose axis. Front Neurosci 2013; 7: 51.
30. Saladin R, De Vos P, Guerre-Millo M etal. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377: 527-529.
31. Koopmans SJ, Frolich M, Gribnau EH, Westendorp RG, DeFronzo RA. Effect of hyperinsulinemia on plasma leptin concentrations and food intake in rats. Am J Physiol 1998; 274: E998-E1001.
32. Saad MF, Khan A, Sharma A etal. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998; 47: 544-549.
33. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
34. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000; 49: 883-888.
35. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 2003; 52: 682-687.
36. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001; 25: 1680-1688.
37. Brabant G, Horn R, von zur Muhlen A etal. Free and protein bound leptin are distinct and independently controlled factors in energy regulation. Diabetologia 2000; 43: 438-442.
38. Cohen SS, Fowke JH, Cai Q etal. Differences in the association between serum leptin levels and body mass index in black and white women: a report from the Southern Community Cohort Study. Ann Nutr Metab 2012; 60: 90-97.
39. Lee SA, Kallianpur A, Xiang YB etal. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007; 16: 2464-2470.